82 related articles for article (PubMed ID: 10646728)
41. [Suppressive mechanism of clarithromycin on lipopolysaccharide-induced IL-8 production in human monocytes by mediating AP-1 and NF-kappaB].
Kikuchi T; Hagiwara K; Honda Y; Watanabe A; Nukiwa T
Jpn J Antibiot; 2003 Apr; 56 Suppl A():100-5. PubMed ID: 14679759
[No Abstract] [Full Text] [Related]
42. [Effects of macrolides on several transcription factors].
Dezaki S; Takizawa H; Morita K; Yamamoto K
Jpn J Antibiot; 2000 Jan; 53 Suppl A():93-4. PubMed ID: 10756462
[No Abstract] [Full Text] [Related]
43. Clarithromycin inhibits fibroblast migration.
Kohyama T; Yamauchi Y; Takizawa H; Itakura S; Kamitani S; Kato J; Nagase T
Respir Med; 2008 Dec; 102(12):1769-76. PubMed ID: 18701271
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells.
Suzuki H; Shimomura A; Ikeda K; Furukawa M; Oshima T; Takasaka T
Laryngoscope; 1997 Dec; 107(12 Pt 1):1661-6. PubMed ID: 9396683
[TBL] [Abstract][Full Text] [Related]
45. [Effect of macrolide antibiotics on VEGF production in nasal mucosa fibroblasts cultured under hypoxic conditions].
Ushikai M; Sun D; Ohori J; Matsune T; Kurono Y
Jpn J Antibiot; 2003 Apr; 56 Suppl A():89-90. PubMed ID: 14679755
[No Abstract] [Full Text] [Related]
46. [Il-8 secretion by cultured epithelial cells of human nasal mucosa and its suppression by macrolide antibiotics].
Suzuki H; Shimomura A; Ikeda K; Furukawa M; Wataya H; Takasaka T
Jpn J Antibiot; 1997 Mar; 50 Suppl A():68-70. PubMed ID: 9597442
[No Abstract] [Full Text] [Related]
47. [Clarithromycin suppression of DNA synthesis by rat nasal mucosal cells enhanced by endotoxin instillation].
Tonai A; Hashiba M; Baba S
Jpn J Antibiot; 1997 Mar; 50 Suppl A():65-7. PubMed ID: 9678983
[No Abstract] [Full Text] [Related]
48. Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production.
Yamamoto S; Ogasawara N; Yamamoto K; Uemura C; Takaya Y; Shiraishi T; Sato T; Hashimoto S; Tsutsumi H; Takano K; Himi T; Yokota SI
Biochem Biophys Res Commun; 2017 Feb; 483(3):911-916. PubMed ID: 27998764
[TBL] [Abstract][Full Text] [Related]
49. Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis.
Rhee CS; Majima Y; Arima S; Jung HW; Jinn TH; Min YG; Sakakura Y
Ann Otol Rhinol Laryngol; 2000 May; 109(5):484-7. PubMed ID: 10823478
[TBL] [Abstract][Full Text] [Related]
50. [Anti-bacterial and anti-inflammatory actions of clarithromycin against Haemophilus influenzae that has infiltrated the respiratory epithelial cells].
Yamazaki Y; Tanabe T; Ushiki A; Kubo K
Jpn J Antibiot; 2009 Mar; 62 Suppl A():48-51. PubMed ID: 22452055
[No Abstract] [Full Text] [Related]
51. [Effects of macrolide antibiotics on neutrophil infiltration into the airway mucosa and ICAM-1 expression].
Isono K; Tamaoki J; Nishimura K; Takeyama R; Nagai A
Jpn J Antibiot; 1998 Jan; 51 Suppl A():34-7. PubMed ID: 9597480
[No Abstract] [Full Text] [Related]
52. Clarithromycin suppresses proliferation of rat nasal epithelium exposed to endotoxin.
Tohnai A; Hashiba M; Baba S
Am J Rhinol; 1998; 12(6):451-7. PubMed ID: 9883303
[TBL] [Abstract][Full Text] [Related]
53. [Neutrophil count and IL-8 level of nasal secretion of patients with chronic paranasal sinusitis and the effects of macrolide antibiotics].
Fujita K; Shimizu T; Usui T; Majima Y; Sakakura Y
Jpn J Antibiot; 1998 Jan; 51 Suppl A():124-7. PubMed ID: 9597505
[No Abstract] [Full Text] [Related]
54. [Inhibitory effect of clarithromycin on NF-kappaB activation].
Ichiyama T; Nishikawa K; Yoshitomi T; Hasegawa T; Matsubara T; Furukawa S
Jpn J Antibiot; 2001 Dec; 54 Suppl C():46-8. PubMed ID: 12575416
[No Abstract] [Full Text] [Related]
55. [Macrolide antibiotic actions on bacteria and cultured airway cells].
Takeda H; Abe S; Nakamura H; Tomoike H
Jpn J Antibiot; 1997 Mar; 50 Suppl A():86-8. PubMed ID: 9597448
[No Abstract] [Full Text] [Related]
56. [Calcium dependent effect of clarithromycin on IL-8 production in cultured human epidermal cells].
Komiya N; Tamaoki K
Jpn J Antibiot; 2001 Feb; 54 Suppl A():123-4. PubMed ID: 11439889
[No Abstract] [Full Text] [Related]
57. Clarithromycin transport by gingival fibroblasts and epithelial cells.
Chou CH; Walters JD
J Dent Res; 2008 Aug; 87(8):777-81. PubMed ID: 18650552
[TBL] [Abstract][Full Text] [Related]
58. [Effect of clarithromycin on adhesion and infiltration of cancer cells].
Shibuya N; Zou DT; Hibino S; Ono Y; Shinoda K; Matsuda K; Kokubo Y; Takeichi A; Azuma A; Kudo S
Jpn J Antibiot; 2000 Jan; 53 Suppl A():48-51. PubMed ID: 10756451
[No Abstract] [Full Text] [Related]
59. [Effect of clarithromycin on KL-8 formation by epidermal keratocytes].
Matsunaga Y; Katayama I; Kadoyama J
Jpn J Antibiot; 2000 Jan; 53 Suppl A():68-9. PubMed ID: 10756455
[No Abstract] [Full Text] [Related]
60. Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma.
Takemori N; Ooi HK; Imai G; Hoshino K; Saio M
Ecancermedicalscience; 2020; 14():1088. PubMed ID: 33014130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
